Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Day

Showing results (1131-1140 of 1,167) with videos related to

Pageof 117
Sort By:
Cancer|May 8, 2014
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinomaMaha Hussain, Stephanie Daignault, Neeraj Agarwal, et al.
HGG Advances|May 14, 2023
<i>De novo</i> variants in <i>GATAD2A</i> in individuals with a neurodevelopmental disorder: GATAD2A-related neurodevelopmental disorderElizabeth A Werren, Alba Guxholli, Natasha Jones, et al.
Science Translational Medicine|December 1, 2021
Repeated <i>Plasmodium falciparum</i> infection in humans drives the clonal expansion of an adaptive γδ T cell repertoireAnouk von Borstel, Priyanka Chevour, Daniel Arsovski, et al.
Cancer Research|October 30, 2016
HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to BoneKathleen C Day, Guadalupe Lorenzatti Hiles, Molly Kozminsky, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adultsCheryl L Day, Michele Tameris, Nazma Mansoor, et al.
Stroke|February 4, 2021
Integrated Stroke System Model Expands Availability of Endovascular Therapy While Maintaining Quality OutcomesVictor Lopez-Rivera, Sergio Salazar-Marioni, Rania Abdelkhaleq, et al.
Clinical Colorectal Cancer|November 23, 2018
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM StudyJeremy D Shapiro, Subotheni Thavaneswaran, Craig R Underhill, et al.
JCI Insight|January 27, 2026
Rare variable M. tuberculosis antigens induce predominant Th17 responses in human infectionPaul Ogongo, Liya Wassie, Anthony Tran, et al.
Annals of Surgery|April 1, 1981
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Ebiomedicine|February 28, 2026
Infection with Mycobacterium tuberculosis depletes host fatty acids in humans and non-human primatesJeffrey M Collins, Liya Wassie, Kidist Bobosha, et al.
Pageof 117

Showing results (1131-1140 of 1,167) with videos related to

Sort By:
Pageof 117
Cancer|May 8, 2014
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinomaMaha Hussain, Stephanie Daignault, Neeraj Agarwal, et al.
HGG Advances|May 14, 2023
<i>De novo</i> variants in <i>GATAD2A</i> in individuals with a neurodevelopmental disorder: GATAD2A-related neurodevelopmental disorderElizabeth A Werren, Alba Guxholli, Natasha Jones, et al.
Science Translational Medicine|December 1, 2021
Repeated <i>Plasmodium falciparum</i> infection in humans drives the clonal expansion of an adaptive γδ T cell repertoireAnouk von Borstel, Priyanka Chevour, Daniel Arsovski, et al.
Cancer Research|October 30, 2016
HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to BoneKathleen C Day, Guadalupe Lorenzatti Hiles, Molly Kozminsky, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adultsCheryl L Day, Michele Tameris, Nazma Mansoor, et al.
Stroke|February 4, 2021
Integrated Stroke System Model Expands Availability of Endovascular Therapy While Maintaining Quality OutcomesVictor Lopez-Rivera, Sergio Salazar-Marioni, Rania Abdelkhaleq, et al.
Clinical Colorectal Cancer|November 23, 2018
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM StudyJeremy D Shapiro, Subotheni Thavaneswaran, Craig R Underhill, et al.
JCI Insight|January 27, 2026
Rare variable M. tuberculosis antigens induce predominant Th17 responses in human infectionPaul Ogongo, Liya Wassie, Anthony Tran, et al.
Annals of Surgery|April 1, 1981
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent diseaseC L Day, A J Sober, A W Kopf, et al.
Ebiomedicine|February 28, 2026
Infection with Mycobacterium tuberculosis depletes host fatty acids in humans and non-human primatesJeffrey M Collins, Liya Wassie, Kidist Bobosha, et al.
Pageof 117